Monetary Solutions’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Other funds holding CRSP
Monetary Solutions's CRSP Position: Q3 2026 in Review
Monetary Solutions held its CRISPR Therapeutics (CRSP) position steady in Q3 2026 at 80 shares worth $4.43K. The position accounts for ﹤0.01% of the portfolio, ranked #253.
Monetary Solutions first reported a position in CRSP in Q4 2025 and has held it in 4 quarters since. 496 funds tracked by Wall St. Rank hold CRSP as of Q3 2026.
- Monetary Solutions held 80 shares of CRISPR Therapeutics worth $4.43K as of Q3 2026.
- Monetary Solutions left its CRISPR Therapeutics share count unchanged in Q3 2026.
- CRISPR Therapeutics made up ﹤0.01% of Monetary Solutions's portfolio in Q3 2026, its #253 holding.
- Monetary Solutions first reported a position in CRISPR Therapeutics in Q4 2025 and has held it in 4 quarters since.
- 496 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2026.
Based on Monetary Solutions's 13F filing for Q3 2026, filed 22 Oct 2026.